Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-04-07 to 2022-04-18
Current total value of award: $42.9
Description: 8509012125!GUAIFENESIN AND DEX